Great Lakes Retirement Inc. Invests $583,000 in Zoetis Inc (NYSE:ZTS)

Great Lakes Retirement Inc. acquired a new stake in Zoetis Inc (NYSE:ZTS) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 4,453 shares of the company’s stock, valued at approximately $583,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Ipswich Investment Management Co. Inc. grew its position in Zoetis by 3.1% in the fourth quarter. Ipswich Investment Management Co. Inc. now owns 2,459 shares of the company’s stock valued at $325,000 after purchasing an additional 75 shares in the last quarter. Enterprise Financial Services Corp lifted its stake in shares of Zoetis by 3.5% during the 4th quarter. Enterprise Financial Services Corp now owns 2,200 shares of the company’s stock worth $291,000 after buying an additional 75 shares during the last quarter. Nations Financial Group Inc. IA ADV boosted its holdings in shares of Zoetis by 0.6% during the 4th quarter. Nations Financial Group Inc. IA ADV now owns 12,425 shares of the company’s stock worth $1,644,000 after buying an additional 75 shares during the period. Doyle Wealth Management boosted its holdings in shares of Zoetis by 1.8% during the 4th quarter. Doyle Wealth Management now owns 4,322 shares of the company’s stock worth $572,000 after buying an additional 77 shares during the period. Finally, Wealthstreet Investment Advisors LLC grew its stake in Zoetis by 2.9% in the 4th quarter. Wealthstreet Investment Advisors LLC now owns 2,831 shares of the company’s stock valued at $374,000 after buying an additional 81 shares during the last quarter. Institutional investors and hedge funds own 91.81% of the company’s stock.

ZTS has been the subject of several research reports. Raymond James initiated coverage on shares of Zoetis in a research report on Thursday, January 9th. They set a “market perform” rating for the company. UBS Group lifted their price target on shares of Zoetis from $126.00 to $146.00 and gave the company a “neutral” rating in a research report on Wednesday, February 19th. Goldman Sachs Group reiterated a “buy” rating and issued a $162.00 price target on shares of Zoetis in a research note on Friday, February 28th. SunTrust Banks reissued a “hold” rating and set a $145.00 price target on shares of Zoetis in a research report on Friday, February 14th. Finally, Bank of America restated a “hold” rating and set a $145.00 price objective on shares of Zoetis in a research note on Wednesday, February 12th. Eight investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $137.25.

Shares of ZTS stock opened at $108.21 on Thursday. The stock’s fifty day moving average price is $131.40 and its two-hundred day moving average price is $128.30. The company has a market cap of $49.28 billion, a PE ratio of 34.68, a P/E/G ratio of 2.39 and a beta of 0.74. Zoetis Inc has a fifty-two week low of $90.14 and a fifty-two week high of $146.26. The company has a debt-to-equity ratio of 2.26, a quick ratio of 1.85 and a current ratio of 2.63.

Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.88 by $0.04. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Zoetis had a net margin of 23.96% and a return on equity of 69.41%. The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.79 EPS. On average, equities analysts predict that Zoetis Inc will post 3.94 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 1st. Shareholders of record on Friday, April 17th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend is Thursday, April 16th. Zoetis’s dividend payout ratio (DPR) is currently 21.98%.

In other news, EVP Roman Trawicki sold 2,199 shares of Zoetis stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $137.41, for a total transaction of $302,164.59. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Heidi C. Chen sold 15,329 shares of the business’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $139.81, for a total transaction of $2,143,147.49. Following the completion of the sale, the executive vice president now directly owns 26,792 shares in the company, valued at approximately $3,745,789.52. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 137,456 shares of company stock valued at $19,499,222. Corporate insiders own 0.29% of the company’s stock.

Zoetis Profile

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.

Read More: Hold Rating

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.